Stem Cell-Derived Endothelial Cell function study

Status

recruiting iconRECRUITING

Purpose

Looking for patients with early-onset hypertension (i.e. less than 40 years of age) in whom secondary causes have been ruled out clinically.

Inclusion/Exclusion criteria:

Patients may be taking anti-hypertensive medications. No restrictions on level of blood pressure or type of antihypertensive medications.

Patients would need to complete only one visit and a blood test (to obtain iPSCs for reprogramming to endothelial cells)

Investigator(s)

Joseph C. Wu
Joseph C. Wu
Cardiologist
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology